Novavax, Inc. (NVAX)
10.46
-0.14
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
10.44
-0.02
(-0.19%)
After-Hours: 20:00
Novavax Profit Margin (Quarterly) : -94.16% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -94.16% |
| March 31, 2026 | -6.80% |
| December 31, 2025 | 11.91% |
| September 30, 2025 | -287.3% |
| June 30, 2025 | 44.52% |
| March 31, 2025 | 77.80% |
| December 31, 2024 | -91.76% |
| September 30, 2024 | -143.5% |
| June 30, 2024 | 39.08% |
| March 31, 2024 | -157.2% |
| December 31, 2023 | -61.23% |
| September 30, 2023 | -69.94% |
| June 30, 2023 | 13.67% |
| March 31, 2023 | -363.1% |
| December 31, 2022 | -50.99% |
| September 30, 2022 | -22.95% |
| June 30, 2022 | -274.6% |
| March 31, 2022 | 28.89% |
| December 31, 2021 | -380.9% |
| September 30, 2021 | -180.3% |
| June 30, 2021 | -118.2% |
| March 31, 2021 | -49.80% |
| December 31, 2020 | -63.49% |
| September 30, 2020 | -125.7% |
| June 30, 2020 | -49.30% |
| Date | Value |
|---|---|
| March 31, 2020 | -765.9% |
| December 31, 2019 | -361.0% |
| September 30, 2019 | -719.7% |
| June 30, 2019 | -1.18K% |
| March 31, 2019 | -1.09K% |
| December 31, 2018 | -805.2% |
| September 30, 2018 | -576.2% |
| June 30, 2018 | -413.0% |
| March 31, 2018 | -480.2% |
| December 31, 2017 | -488.3% |
| September 30, 2017 | -534.1% |
| June 30, 2017 | -660.5% |
| March 31, 2017 | -772.1% |
| December 31, 2016 | -1.06K% |
| September 30, 2016 | -2.05K% |
| June 30, 2016 | -3.17K% |
| March 31, 2016 | -1.83K% |
| December 31, 2015 | -1.35K% |
| September 30, 2015 | -507.6% |
| June 30, 2015 | -147.5% |
| March 31, 2015 | -246.7% |
| December 31, 2014 | -469.2% |
| September 30, 2014 | -240.2% |
| June 30, 2014 | -216.3% |
| March 31, 2014 | -185.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | -8.06% |
| Pfizer Inc. | -1.64% |
| Agenus, Inc. | -1.64% |
| Editas Medicine, Inc. | -153.3% |
| Recursion Pharmaceuticals, Inc. | -1.71K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -21.74% |
| Return on Invested Capital | -161.3% |
| Gross Profit Margin (Quarterly) | 77.70% |
| Operating Margin (Quarterly) | -89.61% |
| Return on Net Operating Assets | -76.67% |